Table 1. Ten Key Challenges for Cancer Immunotherapy 1. Development of pre-clinical models that translate to human immunity 2. Determining the dominant drivers of cancer immunity 3. Understanding organ-specific tumor immune contexture 4. Understanding the molecular and cellular drivers of primary versus...
Takei, S.; Kawazoe, A.; Shitara, K. The New Era of Immunotherapy in Gastric Cancer.Cancers2022,14, 1054. 5.High-MannoseN-Glycans as Malignant Progression Markers in Early-Stage Colorectal Cancer 高甘露糖型N-聚糖作为早期大...
近日,一篇发表在国际杂志Cancer Cell上题为“Interferon-stimulated neutrophils as a predictor of immunotherapy response”的研究报告中,来自以色列理工学院等机构的科学家们通过研究发现了一种能预测免疫疗法成功的血细胞亚群,这些研究发现或有望帮助简化将免疫疗法与特定患者相互匹配的过程,因为提前确定哪些病人会对某种疗...
7. Liu J, Yang Y, Liu Z, et al. Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma[J]. Journal for Immunotherapy o...
Immunotherapy: Treatments with the potential to significantly extend survival for cancer patients, without the negative side effects and related health care costs of traditional chemotherapy Artificial intelligence: The ability of computers to think like and complete tasks currently performed by humans with...
Risedronate-functionalized manganese-hydroxyapatite amorphous particles: A potent adjuvant for subunit vaccines and cancer immunotherapy Triple functional mild photothermal improves gene editing of PD-L1 for enhanced antitumor immunity 2.从收到稿件到接受稿件用时:4.4个月 ...
Over the last few years, Merck & Co has made their way up the ranks thanks to their blockbuster cancer immunotherapy, Keytruda. In 2023, Keytruda accounted for over 46% of the company’s pharmaceutical revenues, with sales reaching US$25bn (+19%). Increased sales for Gardasil HPV vaccine ...
In the mid-1970s, more than half of the patients diagnosed with cancer in the United States failed to survive five years. Today, that picture has changed dramatically.
and the discovery of new top 10 cancer drugs has been hampered by reduced research funding. In addition, pharmaceutical companies that develop and market cancer drugs may face challenges during a recession due to pricing pressures and lower patient access which further hamper top 10 cancer drugs ...
期刊简介 美国医学-免疫学类期刊Journal for ImmunoTherapy of Cancer创刊于2013年,2017年获得第一个影响因子,是美国癌症免疫治疗学会(SITC)的官方期刊,由国际著名出版商BMJ PUBLISHING GROUP出版,发表关于…